Key facts
- This page summarizes Peter Behner's Form 4 filing for MiNK Therapeutics, Inc. (INKT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Sep 2025, 17:26.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.